M Pharmaceutical Announces Shares for Debt Transaction

M Pharmaceutical (CSE:MQ,OTCQB:MPHMF) has announced a shares for debt transaction with ProActive Capital Resources Group LLC.
As quoted in the press release:

M Pharmaceutical Inc., ( the “Company”) (CSE:MQ), a Canadian company committed to developing and commercializing innovative biomedical technologies that improve the health and quality of life for people affected by obesity and diabetes, announced today that it will be issuing 369,200 Common Shares to ProActive Capital Resources Group LLC, dba PCG Advisory Group (“PCG”), to settle five months of fees owed by the Company to PCG, at a deemed price of $0.12 per share, representing in aggregate $44,304. The Shares, when issued, will be subject to a four month hold period under applicable law.

Click here to read the full M Pharmaceutical (CSE:MQ,OTCQB:MPHMF) press release.
Click here to read the full M Pharmaceutical (CSE:MQ,OTCQB:MPHMF) profile.